about
Akt signaling dynamics in individual cells.mTOR signaling in tumorigenesisSignaling specificity in the Akt pathway in biology and disease.Endothelial Akt1 mediates angiogenesis by phosphorylating multiple angiogenic substrates.Distinct actions of akt1 on skeletal architecture and functionRab14 Act as Oncogene and Induce Proliferation of Gastric Cancer Cells via AKT Signaling Pathway.Enhanced phosphatidylinositol 3-kinase (PI3K)/Akt signaling has pleiotropic targets in hippocampal neurons exposed to iron-induced oxidative stressUpregulated WDR26 serves as a scaffold to coordinate PI3K/ AKT pathway-driven breast cancer cell growth, migration, and invasion.AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins.Signalling specificity in the Akt pathway in breast cancer.Triple-negative breast cancer: investigating potential molecular therapeutic target.Phosphatidylinositolphosphate phosphatase activities and cancer.Quantification of growth factor signaling and pathway cross talk by live-cell imaging.Akt2 and p-Akt overexpression in oral cancer cells is due to a reduced rate of protein degradation.Akt as a target for cancer therapy: more is not always better (lessons from studies in mice).Suppressive effect of formononetin on platelet-derived growth factor-BB-stimulated proliferation and migration of vascular smooth muscle cells.The roles of akt isoforms in the regulation of podosome formation in fibroblasts and extracellular matrix invasion.Protein kinase B/AKT isoform 2 drives migration of human mesenchymal stem cellsProtein kinase Akt activity in human thyroid tumors.
P2860
Q27340143-1D4F877A-BCA8-4D23-97A6-79FFF4A81793Q28252695-5305E545-6904-4DA5-9137-82AACC39BE94Q33775212-61AD16A4-DCE4-4E78-BF12-664F4BDB7D98Q34144300-C6710DBE-C645-435F-8832-20FE6DF47FD1Q35129460-EBE83047-D661-4A67-B195-E6D12F5E289CQ36255976-7ECAF2BB-C102-4E73-854E-7ED90004216BQ37000600-BA6F25D8-3B83-47D7-96E2-60D6146181C9Q37109616-21BBA34A-F97F-4DFD-A304-6242511A87E1Q37695410-15E5D839-2323-4BDF-9C6E-838420F52C4EQ38252278-F7021CF5-D8F1-4BE4-A11C-913C3F554B24Q38259322-89AE60B1-E5E8-460B-8809-3D3E1C12BD47Q38572786-5903CDCE-0703-45FA-B4C0-6F540AF5A64AQ38720684-88F13EFB-6080-4D77-AE5C-15414C88CC91Q38833592-0EF12707-BEE8-4F84-8D09-E3C96E32DB66Q39338602-D15BDCE7-2082-4396-B44E-3D704B44509BQ41181621-9FEA697C-4E80-4435-89FB-EC3EC39211C6Q41600042-DA5AB539-8069-4A20-90B5-51AE1C0A15C6Q41910664-DE9CA858-0EB1-48EB-BE89-DBE04FBC24C6Q47672156-6DC871F3-4A30-4A7D-9566-6FC0CAFE49C3
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Achieving specificity in Akt signaling in cancer.
@ast
Achieving specificity in Akt signaling in cancer.
@en
type
label
Achieving specificity in Akt signaling in cancer.
@ast
Achieving specificity in Akt signaling in cancer.
@en
prefLabel
Achieving specificity in Akt signaling in cancer.
@ast
Achieving specificity in Akt signaling in cancer.
@en
P2860
P1476
Achieving specificity in Akt signaling in cancer.
@en
P2093
Alex Toker
P2860
P356
10.1016/J.ADVENZREG.2011.09.020
P577
2012-01-01T00:00:00Z